AW/EPO-002

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameAW/EPO-002
Drug Alias NameAW-EPO002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxidases inhibitors
TargetsPeroxidases
Therapy Area/IndicationsAsthmaColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInoxia Lifesciences GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInoxia Lifesciences GmbH
Active IndicationsN/A
Inactive IndicationsAsthmaColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A